J. W. Rebuck

532 citations
18 papers · 385 indexed · h-index 12
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers)Lymphoma Diagnosis and Treatment (2 papers)Entomological Studies and Ecology (1 paper)
Partner nations
United StatesGermany

In The Last Decade

J. W. Rebuck

18 papers receiving 295 citations

Peers

J. W. Rebuck
Comparison fields: 5 of 79
  • Immunology 73
  • Pathology and Forensic Medicine 69
  • Genetics 64
  • Oncology 53
  • Epidemiology 52
Replace Carl E. Krill with:
Carl E. Krill United States
T Takubo Japan
Alan V. Richman United States
S. F. Sørensen Denmark
R.L. Dawkins Australia
A Branellec France
P. Moerman Belgium
Ed Nieuwenhuys Netherlands
H. Bashir Australia
M. Weber Germany
J. W. Rebuck relative to Carl E. Krill United States Carl E. Krill's profile →
Citations per field
00.5×1.5×
Carl E. Krill · 1×
Citations per year

Countries citing papers authored by J. W. Rebuck

Since Specialization
Citations

This map shows the geographic impact of J. W. Rebuck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. W. Rebuck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. W. Rebuck more than expected).

Fields of papers citing papers by J. W. Rebuck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. W. Rebuck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. W. Rebuck. The network helps show where J. W. Rebuck may publish in the future.

Co-authorship network of co-authors of J. W. Rebuck

This figure shows the co-authorship network connecting the top 25 collaborators of J. W. Rebuck. A scholar is included among the top collaborators of J. W. Rebuck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. W. Rebuck. J. W. Rebuck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 14
2 70
3 1
4 22
5 3
6 6
7 14
8 39
9 28
10 14
11 12
12 62
13 31
14
Thrombocytopoiesis in man.
2
15 2
16 5
17 25
18 35

About J. W. Rebuck

J. W. Rebuck is a scholar working on Genetics, Hematology and Dermatology, having authored 18 papers that have together received 385 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Entomological Studies and Ecology (1 paper). The work is most often cited by research in Genetics (64 citations), Immunology and Allergy (28 citations) and Hematology (51 citations). J. W. Rebuck has collaborated with scholars based in United States and Germany. Frequent co-authors include Raymond W. Monto, Janet Riddle, John Hodson, Richmond W. Smith, Robert J. Priest, Thomas N. James, Michael J. Brennan, V. K. Vaitkevicius, Robert J. Hartsock and Daina Variakojis. Their work appears in journals such as New England Journal of Medicine, The Lancet and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026